glp 1 risks INFOGRAPHIC: The Hidden of GLP-1 Weight Loss Medications Your guide to GLP-1 side

We also describe the development of incretin-based pharmacotherapy, starting with exendin- 4 and ending with the identification of multi-incretin hormone receptor agonists, which appear to be the next major step in the fight against T2DM and obesity

GLP-1 agonists may lessen alcohol, smoking and possibly drug addictions

Preliminary research indicates they may stop cravings even before people trying to quit feel them.

Compounded GLP-1 alternatives for weight loss provide safe solutions

GLP-1 drugs have become a game-changer in treating obesity and type 2 diabetes, forecast to reach a $100 billion market value by 2030